European Expansion VISUfarma operates across Europe with a growing portfolio in ophthalmic products and devices, presenting multiple opportunities to partner with distributors or healthcare providers in 20+ countries to expand reach and accelerate penetration.

Product Portfolio Strong emphasis on dry eye, MGD, blepharitis, retinal health, glaucoma and related eye care solutions creates cross-sell potential to ophthalmology clinics, optometrists, and hospital networks seeking a comprehensive ocular health offering.

Recent Innovations Recent launches such as Xailin Ectoine and TREHAPAN, along with preservative and phosphate free formulations, highlight a focus on differentiated, patient-friendly products that can be positioned for premium pricing and (re)negotiated distribution agreements.

Strategic Partnerships Alliances with Plastic Bank and potential near-term acquisition interest from Lupin/Nanomi indicate appetite for collaborations and channel partnerships, providing pathways for co-marketing, licensing, or exclusive distribution deals.

Funding Signals Revenue in the low-to-mid multi-million range and active M&A discussions suggest growth trajectory and potential for joint ventures or investment-led expansion, making a compelling case for sales partnerships with scaled distributors and regional players.